Similar efficacy of lopinavir/ritonavir-containing regimens among clades B and F HIV-1-infected individuals in Brazil

被引：6
|
作者：
Diaz, Ricardo Sobhie [1 ]
Vasconcelos, Lucy [2 ]
Hayden, Ricardo L. [3 ]
Tenore, Simone [1 ]
Turcato, Gilberto, Jr. [1 ]
Palacios, Ricardo [1 ]
Sucupira, Maria C. [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] Prefeitura Municipal Sao Paulo, Sao Paulo, Brazil
[3] Santa Casa Santos, Santos, Brazil
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2008年 / 47卷 / 03期
关键词：
D O I：
10.1097/QAI.0b013e31815b0d48
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：399 / 401
页数：3
相关论文
共 50 条
  • [1] Meta-Analysis of the Safety, Tolerability, and Efficacy of Lopinavir/Ritonavir-Containing Antiretroviral Therapy in HIV-1-Infected Women
    Hermes, A.
    Squires, K.
    Fredrick, L.
    Martinez, M.
    Pasley, M.
    Trinh, R.
    Norton, M.
    [J]. HIV CLINICAL TRIALS, 2012, 13 (06): : 308 - 323
  • [2] Efficacy of lopinavir/ritonavir (lop/r)-containing salvage regimens in HIV-1 infected patients
    Badri, S
    Falusi, O
    Max, B
    Barker, D
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1204 - 1204
  • [3] Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients
    Benard, Antoine
    Damond, Florence
    Campa, Pauline
    Peytavin, Gilles
    Descamps, Diane
    Lascoux-Combes, Caroline
    Taieb, Audrey
    Simon, Francois
    Autran, Brigitte
    Brun-Vezinet, Francoise
    Chene, Genevieve
    Matheron, Sophie
    [J]. AIDS, 2009, 23 (09) : 1171 - 1173
  • [4] Population pharmacokinetics of lopinavir/ritonavir (LPVr) in HIV-1-infected patients
    Crommentuyn, KML
    Kappelhoff, BS
    Mulder, JW
    Mairuhu, ATA
    van Gorp, ECM
    Meenhorst, PL
    Huitema, ADR
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 609 - 610
  • [5] Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients
    Crommentuyn, KML
    Kappelhoff, BS
    Mulder, JW
    Mairuhu, ATA
    van Gorp, ECM
    Meenhorst, PL
    Huitema, ADR
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (04) : 378 - 389
  • [6] Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals
    De Maat, MMR
    Mathôt, RAA
    Veldkamp, AI
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    Van Gorp, ECM
    Carlier, H
    Beijnen, JH
    [J]. PHARMACOLOGICAL RESEARCH, 2002, 46 (03) : 295 - 300
  • [7] Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens
    Loutfy, MR
    Raboud, JM
    Walmsey, SL
    Saskin, R
    Montaner, JS
    Hogg, RS
    Thompson, CA
    Harrigan, PR
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : 595 - 602
  • [8] Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen
    Azria, Elie
    Moutafoff, Constance
    Schmitz, Thomas
    Le Meaux, Jean Patrick
    Krivine, Anne
    Pannier, Emmanuelle
    Firtion, Ghislaine
    Compagnucci, Alexandra
    Finkielsztejn, Laurent
    Taulera, Olivier
    Tsatsaris, Vassilis
    Cabrol, Dominique
    Launay, Odile
    [J]. ANTIVIRAL THERAPY, 2009, 14 (03) : 423 - 432
  • [9] Lopinavir Plasma Concentrations and Virological Outcome with Lopinavir-Ritonavir Monotherapy in HIV-1-Infected Patients
    Lopez-Cortes, Luis F.
    Ruiz-Valderas, Rosa
    Sanchez-Rivas, Elena
    Lluch, Amparo
    Gutierrez-Valencia, Alicia
    Torres-Cornejo, Almudena
    BenMarzouk-Hidalgo, Omar J.
    Viciana, Pompeyo
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (08) : 3746 - 3751
  • [10] Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected children
    Fraaij, PLA
    Neubert, J
    Bergshoeff, AS
    van Rossum, AMC
    Hartwig, NG
    Schroten, H
    Korn, K
    Burger, DM
    de Groot, R
    Niehues, T
    [J]. ANTIVIRAL THERAPY, 2004, 9 (02) : 297 - 299
12345